April
20
TriSalus Life Sciences Presents New Data at AACR for SD-101 Delivered by the Proprietary PEDD™ Method in Stage IV Uveal Melanoma Patients With Liver Metastases
DENVER and FORT LAUDERDALE, Fla., April 20, 2023 – TriSalus Life Sciences® Inc., (“TriSalus” or the “Company”),...